[Hypotension induced by molsidomine or trinitroglycerin]

Area of Science:

• Pharmacology
• Cardiovascular Physiology
• Medical Research

Background:

• Molsidomine is a vasodilator agent used for coronary artery disease treatment.
• It exhibits a predominant venous effect.
• Understanding its hemodynamic profile during induced hypotension is crucial.

Purpose of the Study:

• To investigate the hemodynamic effects of intravenous molsidomine during deliberate hypotension.
• To compare these effects with those of nitroglycerin at a similar mean arterial pressure (MAP) reduction.
• To elucidate the mechanisms behind drug-induced hypotension.

Main Methods:

• The study involved 11 dogs subjected to intravenous molsidomine (300 micrograms X kg-1).
• Deliberate hypotension was induced and compared to nitroglycerin-induced hypotension, aiming for a -25% decrease in MAP.
• Hemodynamic parameters, including stroke volume, systemic vascular resistance, and heart rate, were monitored.

Main Results:

• Hypotension was successfully achieved in 5 dogs with both molsidomine and nitroglycerin.
• The primary cause of hypotension was a decrease in stroke volume, attributed to reduced preload.
• Molsidomine induced less systemic vascular resistance and tachycardia compared to nitroglycerin.
• Mean arterial pressure decreased progressively over 30 minutes following molsidomine administration.

Conclusions:

• Molsidomine effectively induces hypotension, primarily through a reduction in preload and stroke volume.
• Its hemodynamic effects differ from nitroglycerin, showing a lesser impact on systemic vascular resistance and heart rate.
• Molsidomine represents a potential therapeutic option in managing cardiovascular conditions requiring controlled hypotension.